FizyoArt LogoFizyoArt

Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.

Transsphenoidal Surgery

In which situations is transsphenoidal surgery performed, how is it done, and what should patients know about recovery and risk? Evidence-based English guide.

Transsphenoidal surgery is an operation used to reach the pituitary gland and selected nearby skull base lesions through the nasal passages and sphenoid sinus, rather than through a larger cranial opening. It is most commonly associated with pituitary adenomas, but depending on anatomy and expertise, it may also be used for other lesions in the sellar or parasellar region. The approach is valued because it can provide targeted access while avoiding a conventional open craniotomy in appropriate cases. [1][2][5]

In which situations is it considered?

The operation is often discussed when a pituitary tumor is causing visual compromise, hormonal excess, mass effect, or other symptoms that make surgery preferable to observation or medical treatment. Not every pituitary lesion requires surgery. Some are followed with imaging and hormone testing, while others respond primarily to medication. This is why the decision is usually made jointly by neurosurgery, endocrinology, radiology, and sometimes ENT/skull base teams. [1][3][4]

Typical goals may include removing tumor tissue, relieving pressure on the optic apparatus, reducing hormone overproduction, and obtaining pathological diagnosis. The exact goal varies by disease type. For example, the surgical priorities in a prolactinoma, a nonfunctioning macroadenoma, and a lesion abutting the optic chiasm may not be identical. [1][3][6]

How is preoperative preparation done?

Preoperative evaluation generally includes MRI, detailed hormonal assessment, visual field testing when appropriate, and a review of nasal and sinus anatomy. This preparation is important because the operation concerns not only tumor removal but also preservation of endocrine and neurological function. Baseline hormone status matters greatly when interpreting postoperative recovery and when planning replacement treatment if needed. [2][4][6]

Patients should also understand the limits of surgery. Some tumors can be fully removed, but others can only be debulked safely because they invade surrounding structures such as the cavernous sinus. That does not necessarily make the operation unsuccessful; in many cases, reducing tumor burden and improving compression symptoms is itself a meaningful result, especially when followed by medical therapy or radiosurgery. [3][5][7]

How is transsphenoidal surgery performed?

Most contemporary procedures are carried out endoscopically through the nostrils. The surgeon advances to the sphenoid sinus and then to the sellar region to expose the lesion. The aim is to remove tumor while protecting the normal pituitary gland, optic structures, carotid arteries, and surrounding anatomy. Because the corridor is narrow and the structures are critical, the procedure is highly specialized. [1][2][5]

After surgery, careful monitoring is essential. Attention is usually paid to vision, fluid balance, sodium levels, urine output, headache, nasal symptoms, and possible cerebrospinal fluid leakage. Hormone replacement may be temporary or permanent in some patients, depending on preoperative pituitary function and the extent of intervention. [2][5][7]

What are the expected benefits, risks, and limits?

Potential benefits include decompression of the optic pathways, improvement of hormone-related syndromes in selected secretory tumors, avoidance of open cranial surgery in many cases, and faster recovery compared with more invasive approaches. Yet no pituitary operation is minor. Complications can include cerebrospinal fluid leak, meningitis, bleeding, visual deterioration, endocrine dysfunction, diabetes insipidus, and incomplete resection. [1][2][5]

The limitations are equally important to discuss. Surgical cure depends on tumor type, size, invasion pattern, and endocrine profile. Some patients will need long-term hormonal follow-up, replacement therapy, repeat surgery, radiation treatment, or medical therapy even after technically successful surgery. Therefore, the procedure should be understood as one part of overall pituitary disease management rather than as an isolated event. [3][4][6]

Recovery and when urgent help is needed

Recovery differs from person to person, but nasal discomfort, fatigue, headaches, and temporary restrictions are common early on. Sudden clear watery drainage from the nose, worsening headache with fever, visual deterioration, confusion, extreme thirst with excessive urination, or significant bleeding requires prompt medical attention because these may signal important postoperative complications. [2][5][7]

Patients should also be told that success is not judged solely by how they feel in the first days after surgery. MRI findings, hormone levels, visual status, and longer-term follow-up are all part of the outcome. Safe care depends on close postoperative monitoring just as much as on the operation itself. [1][4][6]

This content is for general information only. Individual suitability and treatment selection should be reviewed with the neurosurgical and endocrine team. [1][2]

References

  1. 1.Mayo Clinic. Transsphenoidal surgery. 2025. https://www.mayoclinic.org/tests-procedures/transsphenoidal-surgery/about/pac-20583059
  2. 2.University College London Hospitals NHS Foundation Trust. Endoscopic transsphenoidal pituitary surgery. Accessed 2026. https://www.uclh.nhs.uk/patients-and-visitors/patient-information-pages/endoscopic-transsphenoidal-pituitary-surgery
  3. 3.The Pituitary Foundation. Surgery. 2023. https://www.pituitary.org.uk/information/surgery/
  4. 4.Pituitary Society. Pituitary Society Guidelines. Accessed 2026. https://pituitarysociety.org/guidelines/
  5. 5.Zubair A, et al. Transsphenoidal Hypophysectomy. StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK556142/
  6. 6.Shafiq I, et al. Advancement in perioperative management of pituitary adenomas. J Neuroendocrinol. 2024. https://pubmed.ncbi.nlm.nih.gov/38964869/
  7. 7.Hanson M, et al. Perioperative management of endoscopic transsphenoidal pituitary surgery. J Neurol Surg B Skull Base. 2020. https://pubmed.ncbi.nlm.nih.gov/32596652/
  8. 8.Zada G, et al. Perioperative management of patients undergoing transsphenoidal pituitary surgery. Asian J Neurosurg. 2010. https://pubmed.ncbi.nlm.nih.gov/22028737/